Quantum Diamond Technologics is developing quantum sensing technology for biomedical research and drug discovery. To enhance the current state of biomarker diagnostics, more accurate, highly sensitive and simple to use platforms are required. Quantum has created their QDTI platform to capitalize on the advances of quantum technologies that revolutionize the process and transmission of information so faster and more precise measurements can be made. Based on research at Harvard University, Quantum is exploiting quantum systems engineered into diamond crystals, called nitrogen vacancy centers, that are the engine to power their biomolecule detection. Besides proteins, Quantum has built their platform to detect nucleic acids and cells facilitating assay development and partnership opportunities for researchers.

Quantum Diamond Technologics

Founded: 2015
Location: Waltham, MA
Employee range: 11 - 50
Funding: &lt;10M

Short description:

Drug notes:

Long description:

Jobs: